LGND
Ligand Pharmaceuticals Inc
Price:  
79.96 
USD
Volume:  
72,484.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LGND Probability of Bankruptcy

The Probability of Bankruptcy of Ligand Pharmaceuticals Inc (LGND) is 35.49% . This number represents the probability that LGND will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating LGND's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

LGND - ESG ratings

ESG ratings are directly linked to the cost of capital and LGND's ability to raise funding, both of which can significantly affect the probability of Ligand Pharmaceuticals Inc going bankrupt.

ESG Score 29.76
Environment Score 13.12
Social Score 20.33
Governance Score 55.82
Returns
Historical Returns (5 day) -0.84%
Historical Returns (MTD) -5.98%
Historical Returns (YTD) 11.96%
Historical Returns (13 week) 9.59%
Historical Returns (26 week) 18.72%
Historical Returns (52 week) 9.40%
Efficiency
Asset Turnover 0.15
Receiveable Turnover 4.11
Gross Margin 90.70%
Operating Margin -0.04%
Pretax Margin 366.22%
Net Margin 278.07%
Return on Asset (ROA) 11.94
Return on Equity (ROE) 13.57
Return on Investments (ROI) 13.57
Price Metrics
Market Cap (M) 1,436.08
Enterprise Value (M)
52 Week High 94.57
52 Week Low 49.24
Beta 1.36
Average Volume (10 day) 0.10
Average Volume (3 month) 0.17
Price / Earnings (P/E) 14.92
Price / Sales (P/S) 12.15
Earnings
EPS 5.23
Revenue CAGR (5 year) -12.19%
Risk
Current Ratio 20.70
Quick Ratio 19.44